Thread: Oral Laquinimod for Multiple Sclerosis Granted Fast Track Status by FDA
View Single Post
Old 02-20-2009, 02:21 AM
Lady's Avatar
Lady Lady is offline
Senior Member
  
Join Date: Aug 2006
Location: East Coast USA
Posts: 1,174
15 yr Member
Lady Lady is offline
Senior Member
Lady's Avatar
 
Join Date: Aug 2006
Location: East Coast USA
Posts: 1,174
15 yr Member
Default Oral Laquinimod for Multiple Sclerosis Granted Fast Track Status by FDA
Press Release

Oral Laquinimod for Multiple Sclerosis Granted Fast Track Status by FDA Jerusalem, Israel and Lund, Sweden, February 12, 2009 - Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) and Active Biotech (NASDAQ OMX NORDIC: ACTI) today announced that oral laquinimod, an investigational treatment for relapsing-remitting multiple sclerosis (RRMS), has received a Fast Track designation from the U.S. Food and Drug Administration (FDA).

Teva completed enrollment for the first of its two Phase III clinical trials for laquinimod (ALLEGRO) in November 2008 and is currently enrolling RRMS patients globally for the second Phase III study (BRAVO).

to read the full report please go to
http://www.tevapharm.com/pr/2009/pr_823.asp

I wonder what the cost of a daily pill will be? Can't be the same as injectables, can it? It is so far just for those with RRMS.
__________________
LADY

May happiness be at your door. May it knock early, stay late, and leave the gift of good health behind.


"Life is what it is". We can only focus on controlling those things we can control, we must let go of the things we can't.
Last edited by Chemar; 02-21-2009 at 01:48 PM. Reason: copyright
Lady is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
Desinie (02-20-2009), dmplaura (02-20-2009), Niko (02-20-2009)